Teplizumab offers a completely different approach. Instead of simply replacing insulin, it targets the immune attack that causes type 1 diabetes.

This research highlights the association between AMY1 gene copy number and salivary enzyme activity, with implications for ...

A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...

New stem cell therapy offers hope for type 1 diabetes, freeing patients from insulin. Learn why diverse clinical trial ...

The International Diabetes Federation confirms type 5 diabetes caused by malnutrition, affecting millions of young people living in poverty.

A study found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.

C. difficile is implicated as the causative organism in 10–25% of patients who develop antibiotic-associated diarrhea (AAD), 50–75% of those with antibiotic-associated colitis and 90–100% of ...

The primary objective of the study is to investigate safety of UP421 transplantation in patients with type 1 diabetes, with secondary endpoints including cell survival, immune evasion, and C-peptide ...

A senior nurse from Udupi, Shivakumar Shettigar, received Rs 13.49 lakh compensation after a false Hepatitis C diagnosis cost him a job in Saudi Arabia. The District Consumer Disputes Redressal ...

The next generation of diabetes and weight loss drugs could come in pill form, deliver even greater weight loss results, and ...

MONDAY, June 23, 2025 (HealthDay News) -- Gluten-stimulated interleukin-2 (IL-2) secretion is useful for diagnosis of celiac disease (CeD), according to a study published online June 9 in ...